Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line

Immunity to Plasmodium falciparum in African children has been correlated with antibodies to the P. falciparum erythrocyte membrane protein 1 (PfEMP1) variant gene family expressed on the surface of infected red cells. We immunized Aotus monkeys with a subregion of the Malayan Camp variant antigen (MCvar1) that mediates adhesion to the host receptor CD36 on the endothelial surface and present data that PfEMP1 is an important target for vaccine development. The immunization induced a high level of protection against the homologous strain. Protection correlated with the titer of agglutinating antibodies and occurred despite the expression of variant copies of the gene during recurrent waves of parasitemia. A second challenge with a different P. falciparum strain, to which there was no agglutinating activity, showed no protection but boosted the immune response to this region during the infection. The level of protection and the evidence of boosting during infection encourage further exploration of this concept for malaria vaccine development.

[1]  W. C. Earle,et al.  Enumeration of parasites in the blood of malarial patients , 1932 .

[2]  P. David,et al.  Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen , 1983, The Journal of experimental medicine.

[3]  R. Hayes,et al.  Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[4]  J. Barnwell,et al.  A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. , 1989, The Journal of clinical investigation.

[5]  D. Herrington,et al.  Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. , 1991, The American journal of tropical medicine and hygiene.

[6]  J. Sadoff,et al.  Efficacy trial of a parenteral gonococcal pilus vaccine in men. , 1991, Vaccine.

[7]  C. Newbold,et al.  Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. , 1992, Experimental parasitology.

[8]  Kevin Marsh,et al.  Rapid switching to multiple antigenic and adhesive phenotypes in malaria , 1992, Nature.

[9]  A. Miller,et al.  Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.

[10]  P. Barr,et al.  Protective immunity induced in Aotus monkeys by a recombinant SERA protein of Plasmodium falciparum: further studies using SERA 1 and MF75.2 adjuvant , 1993, Infection and immunity.

[11]  E. Sercarz,et al.  Determinant spreading and the dynamics of the autoimmune T-cell repertoire. , 1993, Immunology today.

[12]  P. Dubois,et al.  Towards a vaccine against asexual blood stage infection by Plasmodium falciparum. , 1995, Research in immunology.

[13]  Joseph D. Smith,et al.  Switches in expression of plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes , 1995, Cell.

[14]  X. Su,et al.  The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytes , 1995, Cell.

[15]  Theodore F. Taraschi,et al.  Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes , 1995, Cell.

[16]  C. Slomianny,et al.  Immune pressure selects for Plasmodium falciparum parasites presenting distinct red blood cell surface antigens and inducing strain-specific protection in Saimiri sciureus monkeys , 1995, The Journal of experimental medicine.

[17]  G. Snounou.  Detection and identification of the four malaria parasite species infecting humans by PCR amplification. , 1996, Methods in molecular biology.

[18]  A. Craig,et al.  Receptor-specific adhesion and clinical disease in Plasmodium falciparum. , 1997, The American journal of tropical medicine and hygiene.

[19]  H. Singh,et al.  Identification of a region of PfEMP1 that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: conserved function with variant sequence. , 1997, Blood.

[20]  Joe D. Cohen,et al.  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. , 1997, The New England journal of medicine.

[21]  Kevin Marsh,et al.  Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria , 1998, Nature Medicine.

[22]  S. Hoffman,et al.  Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. , 1998, The Journal of infectious diseases.

[23]  S. Bennett,et al.  High incidence of asymptomatic malara infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction. , 1998, The American journal of tropical medicine and hygiene.

[24]  R. Snow,et al.  New insights into the epidemiology of malaria relevant for disease control. , 1998, British medical bulletin.

[25]  Christl A. Donnelly,et al.  Immunity to non-cerebral severe malaria is acquired after one or two infections , 1999, Nature Medicine.

[26]  Kevin Marsh,et al.  Antibody Recognition of Plasmodium falciparum Erythrocyte Surface Antigens in Kenya: Evidence for Rare and Prevalent Variants , 1999, Infection and Immunity.

[27]  D. Baruch.  Adhesive receptors on malaria-parasitized red cells. , 1999, Bailliere's best practice & research. Clinical haematology.

[28]  R. Anderson,et al.  Population structure of pathogens: the role of immune selection. , 1999, Parasitology today.

[29]  May Ho,et al.  Molecular mechanisms of cytoadherence in malaria. , 1999, American journal of physiology. Cell physiology.

[30]  P. Kubes,et al.  Visualization of Plasmodium falciparum–Endothelium Interactions in Human Microvasculature , 2000, The Journal of experimental medicine.

[31]  A. Barbour,et al.  Antigenic variation in vector-borne pathogens. , 2000, Emerging infectious diseases.

[32]  D. Kaslow,et al.  Structural conformers produced during malaria vaccine production in yeast , 2001, Yeast.

[33]  A. Podda.  The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. , 2001, Vaccine.

[34]  B. Gamain,et al.  The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes , 2001, Proceedings of the National Academy of Sciences of the United States of America.